ES2160790T3 - 10-aminoalifatil-dibenzo(b,f)oxepinas de accion antineurodegenerativa. - Google Patents

10-aminoalifatil-dibenzo(b,f)oxepinas de accion antineurodegenerativa.

Info

Publication number
ES2160790T3
ES2160790T3 ES96810062T ES96810062T ES2160790T3 ES 2160790 T3 ES2160790 T3 ES 2160790T3 ES 96810062 T ES96810062 T ES 96810062T ES 96810062 T ES96810062 T ES 96810062T ES 2160790 T3 ES2160790 T3 ES 2160790T3
Authority
ES
Spain
Prior art keywords
oxepins
dibenzo
aminoalifatil
antineurodegenerative
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96810062T
Other languages
English (en)
Inventor
Claudia Dr Betschart
Kaspar Dr Zimmermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2160790T3 publication Critical patent/ES2160790T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14—[b,f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)

Abstract

10-AMINOALIFAYIL-DIBENZO[B,F]OXEPINAS DE FORMULA I, DONDE ALK SIGNIFICA UN RADICAL ALIFATICO BIVALENTE, R UN GRUPO AMINO INSUSTITUIDO O SUSTITUIDO POR UN RADICAL ALIFATICO O ARAL HETEROCICLICO; Y N REPRESENTA 0, 1 O 2; TAMBIEN SE PRESENTAN LAS SALES FARMACOLOGICAMENTE ACEPTABLES DE LOS COMPUESTOS. ESTOS COMPUESTOS TIENEN ACTIVIDAD INHIBIDORA DE LA ADMISION DE LA ADENOSINA Y SON UTILES PARA LA PROTECCION DEL MIOCARDIO Y PARA LA PREVENCION O EL TRATAMIENTO DE INFLAMACIONES TALES COMO EL EDEMA DEL PIE.
ES96810062T 1995-02-08 1996-01-30 10-aminoalifatil-dibenzo(b,f)oxepinas de accion antineurodegenerativa. Expired - Lifetime ES2160790T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH36795 1995-02-08

Publications (1)

Publication Number Publication Date
ES2160790T3 true ES2160790T3 (es) 2001-11-16

Family

ID=4185416

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96810062T Expired - Lifetime ES2160790T3 (es) 1995-02-08 1996-01-30 10-aminoalifatil-dibenzo(b,f)oxepinas de accion antineurodegenerativa.

Country Status (27)

Country Link
US (2) US5780500A (es)
EP (1) EP0726265B1 (es)
JP (2) JP3625559B2 (es)
KR (1) KR100485538B1 (es)
CN (1) CN1216052C (es)
AR (1) AR004474A1 (es)
AT (1) ATE203528T1 (es)
AU (1) AU715245B2 (es)
BR (1) BR9600339A (es)
CA (1) CA2168937C (es)
CY (1) CY2333B1 (es)
DE (1) DE59607332D1 (es)
DK (1) DK0726265T3 (es)
ES (1) ES2160790T3 (es)
FI (1) FI120400B (es)
GR (1) GR3036656T3 (es)
HU (1) HU229227B1 (es)
IL (1) IL117067A (es)
MX (1) MX9600503A (es)
MY (1) MY113427A (es)
NO (1) NO314356B1 (es)
NZ (1) NZ280940A (es)
PT (1) PT726265E (es)
RU (1) RU2160734C2 (es)
SA (1) SA01220313A (es)
TW (1) TW420672B (es)
ZA (1) ZA96960B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840749A (en) * 1989-08-25 1998-11-24 Hoechst Marion Roussel, Inc. N-hydroxy-dibenz b,e!oxepinalkylamines, N-hydroxy-dibenz b,e!oxepinalkanoic acid amides and related heterocyclic analogues
AR008371A1 (es) * 1996-05-30 2000-01-19 Novartis Ag Una sal de adicion con acido de una 10-aminoalifatil-dibenz[b,f],oxepina, su empleo; procedimiento para su elaboracion, una 10-aminoalifatil-dibenz[b,f]oxepina, una preparacion farmaceutica que contiene dicha sal o dicha oxepina y un procedimiento para el tratamiento de enfermedades neurodegenerativ
AU3172397A (en) * 1996-06-05 1998-01-05 Novartis Ag Anti-neurodegeneratively effective xanthene derivatives
AU4944297A (en) * 1996-10-08 1998-05-05 Novartis Ag Modulation of apoptosis
EP0979073A4 (en) * 1997-03-31 2004-04-07 Childrens Medical Center NITROSYLATION FOR INACTIVATING APOPTOTIC ENZYMS
PL352840A1 (en) 1999-06-03 2003-09-08 Nippon Suisan Kaisha, Ltd. Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
WO2003057204A2 (en) * 2002-01-08 2003-07-17 Nordic Bioscience A/S Modulation of iamt (pimt or pcmt) in immune system
JP2006516580A (ja) * 2003-01-29 2006-07-06 ノバルティス アクチエンゲゼルシャフト 眼の変性疾患の処置のための１０−アミノアリファチル−ジベンズ［ｂ，ｆ］オキセピンの使用
ZA200603165B (en) * 2003-11-03 2007-07-25 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
US7906180B2 (en) * 2004-02-27 2011-03-15 Molecular Imprints, Inc. Composition for an etching mask comprising a silicon-containing material
EP1757284A1 (en) 2005-08-25 2007-02-28 Santhera Pharmaceuticals (Schweiz) AG Use of N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy
EP1842539A1 (en) * 2006-04-05 2007-10-10 Santhera Pharmaceuticals (Schweiz) AG Use of N- (dibenz(b,f)oxepin-10-ylmethyl)N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency
KR20110087582A (ko) * 2010-01-26 2011-08-03 삼성전자주식회사 식각액 조성물 및 이를 이용한 식각 방법
US9937144B2 (en) 2013-01-30 2018-04-10 The Johns Hopkins University Treatment of drug abuse by preventing GAPDH nitrosylation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3100207A (en) * 1959-07-08 1963-08-06 Smith Kline French Lab 10-aminoalkylbenzo[b,f]thiepin and -dibenz[b,f]oxepin derivatives
DE1493782B1 (de) * 1964-06-29 1969-12-11 Geigy Ag J R Basisch substituierte Dibenzo[b,f]-oxepine und deren nicht-toxische Salze
NL124626C (es) * 1964-06-29
CH440318A (de) * 1964-11-03 1967-07-31 Geigy Ag J R Verfahren zur Herstellung von neuen Thiepin- und Oxepinderivaten
US3641056A (en) * 1970-01-06 1972-02-08 Ciba Geigy Corp 10-(aminomethyl)- and (aminoethyl)-dibenz (b f)oxepins
US3928383A (en) * 1973-06-08 1975-12-23 Hoffmann La Roche Propynylamine-substituted dibenzo{8 b,f{9 thiepins and dibenz{8 b,f{9 oxepins
IE62754B1 (en) * 1988-08-26 1995-02-22 Akzo Nv Tetracyclic antidepressants

Also Published As

Publication number Publication date
RU2160734C2 (ru) 2000-12-20
TW420672B (en) 2001-02-01
HUP9600272A3 (en) 2000-03-28
ZA96960B (en) 1996-08-08
JP2005008646A (ja) 2005-01-13
EP0726265A1 (de) 1996-08-14
ATE203528T1 (de) 2001-08-15
FI120400B (fi) 2009-10-15
AR004474A1 (es) 1998-12-16
MX9600503A (es) 1997-01-31
GR3036656T3 (en) 2001-12-31
AU715245B2 (en) 2000-01-20
FI960529A0 (fi) 1996-02-05
AU4330796A (en) 1996-08-15
IL117067A (en) 2000-08-13
NO314356B1 (no) 2003-03-10
US5780501A (en) 1998-07-14
MY113427A (en) 2002-02-28
NO960499L (no) 1996-08-09
JP3625559B2 (ja) 2005-03-02
FI960529A (fi) 1996-08-09
CN1137039A (zh) 1996-12-04
KR100485538B1 (ko) 2005-09-02
HUP9600272A2 (en) 1997-05-28
EP0726265B1 (de) 2001-07-25
BR9600339A (pt) 1998-01-27
SA01220313A (ar) 2005-12-03
NZ280940A (en) 1997-12-19
JPH08259559A (ja) 1996-10-08
CY2333B1 (en) 2004-02-06
KR960031452A (ko) 1996-09-17
DE59607332D1 (de) 2001-08-30
US5780500A (en) 1998-07-14
PT726265E (pt) 2001-12-28
DK0726265T3 (da) 2001-10-22
HU9600272D0 (en) 1996-04-29
CA2168937A1 (en) 1996-08-09
NO960499D0 (no) 1996-02-07
CA2168937C (en) 2009-10-20
HU229227B1 (en) 2013-09-30
CN1216052C (zh) 2005-08-24
IL117067A0 (en) 1996-06-18

Similar Documents

Publication Publication Date Title
ES2160790T3 (es) 10-aminoalifatil-dibenzo(b,f)oxepinas de accion antineurodegenerativa.
ES2161290T3 (es) Derivados de quinazolina.
ES2116131T3 (es) Derivados de naftaleno, su procedimiento de preparacion y productos intermediarios adecuados, y las composiciones farmaceuticas que los contienen.
CY1106674T1 (el) Αζαδικυκλικοι ετεροκυκλοι σαν ρυθμιστες υποδοχεα κανναβινοειδους
PA8431301A1 (es) Inhibidores de metaloproteinasas, composiciones farmaceuticas que los contienen y sus usos farmaceuticos y los metodos e intermedios utiles para su preparacion
TR200101969T2 (tr) Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları.
PA8507601A1 (es) Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos
UY26782A1 (es) Derivados del benzotiazol
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
RU94046306A (ru) Производные индолокарбазолимида, смесь их изомеров или отдельные изомеры и их соли и фармацевтическая композиция с активностью, ингибирующей протеинкиназу с или киназу легкой миозиновой цепи или подавляющей иммунные реакции
ES2164920T3 (es) Nuevos derivados heterociclicos y uso medicinal de los mismos.
UY26872A1 (es) Derivados de la 4- fenil piridina
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
DE60026155D1 (de) Einige alkylendiamin-substituierte heterocyclen
GT200000037A (es) Procedimientos e intermedios para preparar compuestos anticancerosos.
BG66085B1 (bg) Фенилаланинови производни
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
ES2044874T3 (es) Derivados del acido malonico y metodos para su sintesis.
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
UY28101A1 (es) Ureas substituidas y carbamatos útiles para el tratamiento de la enfermedad de alzheimer
ES2072263T3 (es) Derivados de 4-aminopiridina.
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
AR027050A1 (es) Bencimidazoles, su preparacion y su empleo como medicamentos
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 726265

Country of ref document: ES